Somewhat counterintuitively, we observed a protective effect of the PCSK9 gene showing that across a large population, LoF variants in this gene impose a cholesterol lowering effect and this outweighs the known, but very rare gain of function variation very infrequently observed in families with FH. This evidence concerns the gene PCSK9 and familial hyperaldosteronism.